Silexion Reports Positive Findings for RNAi Candidate SIL204
Silexion Therapeutics reports new findings supporting the cellular uptake and gene-silencing mechanism of its investigational RNAi candidate SIL204.
Gene-silencing Mechanism | 30/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy